Biotech Values

[kris_kade]

‘Dirt cheap’ ? Bit amused. So only dumb retails seeing this EV thesis ? If this was this cheap, wonder why Dan couldn’t sell the story. Either he is uncompetitive or street doesn’t buy RT002 story. May be both.

Now street will look to see sales ramp before being convinced and that’s an Year and half away especially considering current FDA slow down. Dead money as far as I am concerned.